Doyle Janeen Noel 4
4 · Janux Therapeutics, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Transactions
- Award
Common Stock
2026-01-02+36,000→ 80,000 total - Award
Stock option (right to buy)
2026-01-02+126,000→ 126,000 totalExercise: $13.65Exp: 2036-01-01→ Common Stock (126,000 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
- [F2]25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.